drugset / Trial / NCT06804993

Rectocele Repair with or Without Internal Sphincter Botulinum Toxin Injection: a Prospective Randomized Trial

NCT06804993 ↗

Phase 4 Active not recruiting 60 enrolled Mansoura University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a single-centre, prospective randomized controlled trial on female patients with anterior rectocele associated with obstructed defecation syndrome

Timeline

Start
2021-07-31
Primary completion
2023-09-30
Completion
2025-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 30 iu Other